Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Laura Lorenzetti
Stay informed with Laura Lorenzetti’s coverage and analysis for Fortune.
Page 54 of 73
Luxury
7 standout artworks from Sotheby’s and Christie’s fall auctions
By
Laura Lorenzetti
Retail
Diageo trades in Bushmills whiskey for Don Julio tequila
By
Laura Lorenzetti
Virgin Galactic descent device activated early, crash investigators say
By
Laura Lorenzetti
Features
Ebola vaccines and the jobs report — 5 things to watch for this week
By
Laura Lorenzetti
Ex-Apple CEO John Sculley launches low-cost smartphone brand
By
Laura Lorenzetti
Leadership
Apple’s CEO Tim Cook has these 7 openly gay leaders to thank
By
Laura Lorenzetti
Retail
Fortune’s World’s Most Admired Companies: Starbucks, where innovation is always brewing
By
Laura Lorenzetti
Finance
End of an era as the Fed ends its huge bond-buying program
By
Laura Lorenzetti
Finance
Here are 5 things to look out for from the Fed today
By
Laura Lorenzetti
Google X goes teeny-tiny to diagnose disease at its earliest stages
By
Laura Lorenzetti
International
Alibaba heads to Hollywood with its new cash stockpile
By
Laura Lorenzetti
Finance
Pfizer’s sales beats expectations even as top drugs lose patent protections
By
Laura Lorenzetti
Finance
Allergan firms up its profit as it continues to rebuff Valeant’s advances
By
Laura Lorenzetti
Finance
Merck’s cost cutting pays off as results beat expectations
By
Laura Lorenzetti
Features
Facebook and the Fed — 5 things to watch for this week
By
Laura Lorenzetti